Hypera S.A. (OTCMKTS:HYPMY) Short Interest Update

Hypera S.A. (OTCMKTS:HYPMY) was the target of a significant increase in short interest in February. As of February 15th, there was short interest totalling 11,400 shares, an increase of 58.3% from the January 31st total of 7,200 shares. Based on an average daily trading volume, of 9,900 shares, the days-to-cover ratio is currently 1.2 days.

Hypera Price Performance

HYPMY traded down $0.08 during midday trading on Tuesday, hitting $3.10. The stock had a trading volume of 2,798 shares, compared to its average volume of 7,054. The business has a fifty day moving average of $3.16 and a 200 day moving average of $3.92. The company has a quick ratio of 1.41, a current ratio of 1.81 and a debt-to-equity ratio of 0.68. Hypera has a 1 year low of $2.64 and a 1 year high of $6.99.

About Hypera

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.